Ribavirin treatment for possible bornavirus infection

JRCT ID: jRCTs051180130

Registered date:18/03/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: schizophrenia, affective disorders, dementia, others
• Date of first enrollment: 30/11/2020
• Target sample size: 5
• Study type: Interventional
• Intervention(s): Oral administration of riabvirin with the same doses as for hepatitis C

Outcome(s)

• Primary Outcome: Target symptoms will be decided individually
• Secondary Outcome: Other symptoms than the target symptoms

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both

Include criteria

Seropositive for bornavirus
Treatment-resistent neuropsychiatric symptoms

• Exclude criteria: Hemoglobin concenration lower than 10 g/dl

Related Information

• Primary Sponsor: Matsunaga Hidenori